Philip D. Mosier - Concepedia

Concepedia

Author

Philip D. Mosier

Virginia Commonwealth University ORCID

Also Known As

Dewkar, Gajanan K., Dicheva, Nedyalka, Glennon, Richard A., Huben, Krzysztof, Kash, Thomas L., P D Mosier, P.D. Mosier, Peddi, Srinivas, Philip D Mosier, Philip D. Mosier

67

Publications

3.1K

Citations

26

H-Index

73

Concepts

All Affiliations

Virginia Commonwealth University University of North Carolina at Chapel Hill Huazhong University of Science and Technology Pennsylvania State University United States Food and Drug Administration

PD

About

Philip D. Mosier is an author at Virginia Commonwealth University specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	25	2.5K
2	Biochemistry	20	25	1.8K
3	Natural Sciences	15	17	725
4	Engineering	2	2	104
5	Social Sciences	2	2	419

Philip D. Mosier

×

41

Publications

3.1K

Citations

26

H-Index

	Year	Citations
Structure of the human κ-opioid receptor in complex with JDTic Huixian Wu, Daniel Wacker, Mauro Mileni, Nature Molecular PharmacologyMolecular PhysiologySignal TransductionBiochemistryHuman κ-Opioid Receptor	2012	867
A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior Eyal Vardy, J. Elliott Robinson, Chia Li, Neuron Behavioral NeuroscienceMedicineFunctional SelectivityMechanism Of ActionPsychopharmacology	2015	386
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor Tao Che, Susruta Majumdar, Saheem A. Zaidi, Cell Kappa Opioid ReceptorMolecular PharmacologyFunctional SelectivityNanobody-stabilized Active StateMedicine	2018	362
Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions Prem Raj B. Joseph, Philip D. Mosier, Umesh R. Desai, Biochemical Journal GlycobiologyImmunologyMolecular BiologyHeparin-derived OligosaccharidesImmunologic Mechanism	2015	106
Identification of the Molecular Mechanisms by Which the Diterpenoid Salvinorin A Binds to κ-Opioid Receptors Feng Yan, Philip D. Mosier, Richard B. Westkaemper, Biochemistry Salvinorin ADrug TargetFree ThiolChemical BiologyMolecular Pharmacology	2005	91
Structure-Based Design, Synthesis, and Biochemical and Pharmacological Characterization of Novel Salvinorin A Analogues as Active State Probes of the κ-Opioid Receptor Feng Yan, R. V. Bikbulatov, Viorel Mocanu, Biochemistry Salvinorin ABioorganic ChemistryDrug TargetChemical BiologyPharmaceutical Chemistry	2009	81
Finding a Needle in a Haystack: Development of a Combinatorial Virtual Screening Approach for Identifying High Specificity Heparin/Heparan Sulfate Sequence(s) Arjun Raghuraman, Philip D. Mosier, Umesh R. Desai Journal of Medicinal Chemistry	2006	72
Chemotype-selective Modes of Action of κ-Opioid Receptor Agonists Eyal Vardy, Philip D. Mosier, Kevin J. Frankowski, Journal of Biological Chemistry	2013	68
QSAR/QSPR Studies Using Probabilistic Neural Networks and Generalized Regression Neural Networks Philip D. Mosier, Peter C. Jurs Journal of Chemical Information and Computer Sciences Pnn MethodologyEngineeringMachine LearningProbabilistic Neural NetworkMedicinal Chemistry	2002	64
A Hexasaccharide Containing Rare 2‐<i>O</i>‐Sulfate‐Glucuronic Acid Residues Selectively Activates Heparin Cofactor II Nehru Viji Sankaranarayanan, Tamara R. Strebel, Rio S. Boothello, Angewandte Chemie International Edition	2017	60

Page 1